UFLEX Q1 FY27: Revenue surges 38% to ₹5,397 Cr, EBITDA jumps 92% to ₹920 Cr
UFLEX's Q1 FY27 results show a 38% revenue growth to ₹5,397 Cr and a 92% EBITDA jump to ₹920 Cr, marking a 21-quarter high. Overseas operations significantly boosted profitability. The company expects 35% growth in FY27 and aims for leverage below 3x by FY28, driven by new project commissioning.
The substantial growth in key financial metrics (revenue, EBITDA, net profit), margin expansion, and positive future outlook, coupled with the commissioning of significant new projects, are expected to have a material positive impact on the company's financial standing and investor perception.
The company reported significant year-on-year growth in revenue, EBITDA, and net profit, along with margin expansion, indicating strong financial performance. New project commissions and positive future guidance further contribute to the positive sentiment.
UFLEX Limited has reported a strong start to fiscal 2027, with its Q1 FY27 consolidated revenue growing by 38% year-on-year to ₹53,972 million (₹5,397.2 crore). The company's EBITDA saw a significant jump of 92% year-on-year, reaching ₹9,198 million (₹919.8 crore), with EBITDA margins expanding by 480 basis points to 17%. This marks the highest EBITDA performance in the last 21 quarters.
Overseas operations contributed substantially to the growth, accounting for 80% of the incremental revenue and 91% of the incremental EBITDA. Key growth drivers included operations in Egypt, Mexico, and Nigeria, along with the India PET chips business. Consolidated net profit after tax (PAT) surged to ₹4,233 million (₹423.3 crore) from ₹580 million (₹58 crore) in Q1 FY26, with a net margin of 7.8% compared to 1.5%.
Total sales volume for the quarter was 173,471 metric tons, a 1.7% year-on-year increase. Packaging Films volume grew by 4.9% year-on-year to 136,186 metric tons, supported by increased sourcing from regional producers. However, overall Packaging volumes declined by 8.4% to 37,285 metric tons, attributed to a strategic shift towards high-margin products in India and softness in Aseptic Packaging.
Capex incurred in Q1 FY27 amounted to ₹4,782 million, allocated to projects including the Egypt Aseptic facility, Mexico WPP bags, and a recycling unit in Noida. The Noida recycling plant was commissioned on April 30, 2026, and the Mexico WPP bags plant on July 31, 2026. The Greenfield Aseptic project in Egypt is on schedule for commissioning in FY27.
Management guidance indicates an expectation of 35% growth in top-line and EBITDA for FY27 compared to FY26. While Q2 might see some normalization from Q1's exceptional performance, the company anticipates sustained profitable growth driven by increased utilization, localized sourcing, and a shift towards value-added packaging films. The company expects to achieve leverage below 3x by FY28.
What to do with a filing like this
UFLEX Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by UFLEX Limited. Read the original for the full detail.